Harnessing Deubiquitinases (DUBs) as a Novel Therapeutic Modality
Time: 8:30 am
day: Post-Conference Focus Day: Next Generation TPD
Details:
- Identifying high impact targets for targeted deubiquitination therapeutics (TDT)
- Deploying novel ligands for DUB recruitment
- Novel insights into TDT and RESTORAC development
